SBWire

All Eyes On The Global Picture... Still

Colour Cosmetics in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers eye, face, lip and nail colour cosmetics for women. It excludes nail varnish remover, medicated products including lip salves and cosmetics hardware such as false eye lashes and nails. Market value is based on sales through all retail channels including direct to consumer and selective outlets. Market size for Colour Cosmetics in US is given in USD with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for US. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

Sweet Spreads in Indonesia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This report covers packaged; jam, honey and other sweet spreads. Market size comprises sales through all retail channels including direct to consumer. Market size for Sweet Spreads in Indonesia is given in IDR and tonne with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for Indonesia. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

Global Market Direct's pharmaceuticals report, "NeuroSearch A/S - Product Pipeline Review - 2013" provides data on the NeuroSearch A/S's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Kidney Disease - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kidney Disease. Kidney Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Core Views

We hold a cautious outlook on Japan's agribusiness sector. The main marker which will give more cues about the direction of the agriculture industry will be in the outcome of the negotiations about joining in the 11-nation Trans-Pacific Partnership free trade talks. In the near term, the latest lift of a ban on beef imports from the US should lead to a considerable shift in import patterns (from relying mainly on Australian beef to US-origin beef) and also lift overall imports on a whole.

BMI's China tourism report looks at the trends and opportunities offered by the domestic and international tourism market. Inbound and outbound travel are both expected to show exceptional growth between 2013 and 2017, with domestic travel in particular bolstered by an increasingly prevalent and affluent middleclass. Other market indicators including receipts from travel, airline take-offs, number of hotels and industry value all show very positive signs of growth.

Global Market Direct's pharmaceuticals report, "MultiCell Technologies, Inc. - Product Pipeline Review - 2013" provides data on the MultiCell Technologies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The accompanying tables present the latest economic data and five-year forecast scenario for the country's banking system. Also included is a SWOT analysis of the commercial banking system as a whole.

Global Market Direct's pharmaceuticals report, "Elan Corporation, plc - Product Pipeline Review - 2013" provides data on the Elan Corporation, plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

In the five-year period between 2013 and 2017, production growth is set to outpace consumption growth in the Malaysian oil sector as the removal of fuel subsidies and a move towards coalfired power plants reduce domestic demand for oil. Production will continue to be strong given our positive demand forecasts for oil within the Asian region. The trend is reversed in gas, where consumption growth will outpace domestic production growth. Malaysia's gas prices continue to be the lowest in South East Asia, and gas remains the preferred energy fuel by power companies.

Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluent population and strong regulatory conditions. In particular, we highlight that the slowing economy poses opportunities for generic drug players looking to expand in the country. Meanwhile, domestic firms will continue to expand overseas (especially in emerging markets) in order to maintain revenue growth.

Global Market Direct's pharmaceuticals report, "GlaxoSmithKline plc - Product Pipeline Review - 2013" provides data on the GlaxoSmithKline plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

New and emerging classes of mobile devices (smartphones, pc data cards, USB modems, consumer devices with embedded wireless, machine-to-machine, etc.) are fostering explosive growth of wireless data usage by public and enterprise users. As a result, wireless service providers have to simultaneously support a growing number of higher-bandwidth data applications and services on their networks.

The Danish cards and payments industry is one of the most well-developed and highly regulated in the world. The cards and payments industry in Denmark has its roots in the 1960s, when Danish banks were among the first in the world to develop and invest in electronic payment services. In 1983, Danish company PBS A/S introduced the country's national debit card, the Dankort, and since then, the entire payment preferences of consumers have shifted from cash and check payments to the Dankort. Despite growing competition from international payment cards, Dankort and its co-badged solutions still dominate the Danish cards and payments industry. The total number of cards issued in Denmark rose from 10.8 million in 2008 to 12.7 million in 2012, at a CAGR of 4.31% during the review period. Over the forecast period, the prepaid cards category is expected to record a CAGR of 2.36% and will hold a significant share in the industry. The debit card category registered a CAGR of 5.25% during the review period, growing from 5.1 million cards in 2008 to 6.2 million in 2012. Overall, the number of cards across all categories is expected to grow at a CAGR of 1.43% over the forecast period, rising from 13.0 million in 2013 to 13.7 million in 2017.

GlobalData's new report, "Ziehm Imaging GmbH Market Share Analysis" provides in-depth information on Ziehm Imaging GmbH's market position in the C-arms market. The report also provides data and information on the overall competitive landscape within the C-arms market. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

Global Markets Direct's, 'Obsessive-Compulsive Disorder - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Obsessive-Compulsive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder. Obsessive-Compulsive Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Andorra has a small yet relatively wealthy economy driven primarily by the service sector. Tourism and banking sectors are the backbone of the Andorran economy and the country is susceptible to the economic developments of Spain and France, which account for almost all of its tourists. The economy is expected to undergo a challenging phase over the forecast period as the French economy is expected to post a weak CAGR of 1.2% while the Spanish economy will post a CAGR of 0.7%. The insurance industry posted a CAGR of -0.2% during the review period in line with declining economic growth. The industry is projected to grow at a minimal CAGR of 1% due to anticipated sluggish economic performance.

Global Market Direct's pharmaceuticals report, "Sigma-Tau Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Sigma-Tau Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The Philippines Real Estate report examines the commercial office, retail, industrial and construction segments in the context of a sector on the rise. After a year of outperformance in 2011/12 and a strong start to the year, the outlook for the remainder for 2013 remains relatively rosy, although macroeconomic headwinds are on the horizon.

Global Markets Direct's, 'Heart Transplantation - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Heart Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Heart Transplantation. Heart Transplantation - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

GlobalData has released its pharma report, "PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing RSV Market. The report identifies and analyses the key companies shaping and driving the global RSV market. The report provides insight into the competitive RSV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Rises in oil revenues, increased government investment on infrastructure projects and a steadily increasing population are supporting the growth of the insurance industry in the country. The Kuwaiti insurance industry has the lowest insurance penetration rate in the Gulf Cooperation Council (GCC) region. The industry is highly competitive with 34 insurance companies providing insurance services to a population of 3.8 million people. Like other countries in the GCC region, the non-life segment dominates the insurance industry. The majority of Kuwaiti insurance company operations are concentrated in the domestic market with no major geographic diversification. In Kuwait, insurance companies cede a larger percentage of their gross written premium to reinsurers than other companies in the international market.

Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; and medical devices used in a variety of medical specialties. Stryker sells its products across the US, Europe, Japan, Asia Pacific, Canada and Latin America. It sells its products through its subsidiaries and branches, besides third-party dealers and distributors. Stryker is headquartered in Michigan, the US.